Literature DB >> 17434583

What does over-expression of cN-II enzyme signify in haematological malignancies?

Carlos M Galmarini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434583     DOI: 10.1016/j.leukres.2007.02.006

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  4 in total

Review 1.  Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.

Authors:  Christine M Hartford; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2007-09       Impact factor: 2.533

2.  Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.

Authors:  Amit K Mitra; Kristine R Crews; Stanley Pounds; Xueyuan Cao; Tanya Feldberg; Yogita Ghodke; Varsha Gandhi; William Plunkett; M Eileen Dolan; Christine Hartford; Susana Raimondi; Dario Campana; James Downing; Jeffrey E Rubnitz; Raul C Ribeiro; Jatinder K Lamba
Journal:  J Pharmacol Exp Ther       Date:  2011-06-28       Impact factor: 4.030

3.  Cytosolic 5'-nucleotidase II interacts with the leucin rich repeat of NLR family member Ipaf.

Authors:  Federico Cividini; Maria Grazia Tozzi; Alvaro Galli; Rossana Pesi; Marcella Camici; Charles Dumontet; Lars Petter Jordheim; Simone Allegrini
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

4.  Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.

Authors:  Hai-Xia Cao; Chao-Feng Miao; Liang Yan; Ping Tang; Li-Rong Zhang; Ling Sun
Journal:  J Transl Med       Date:  2017-11-15       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.